Lifecore Biomedical, Inc. to Present at CL King's Best Ideas Conference 2007

LIFECORE BIOMEDICAL, INC. (NASDAQ:LCBM) announced today that it will participate in the CL King Best Ideas Conference, to be held Tuesday and Wednesday, September 18-19, 2007, at the Omni Berkshire Place Hotel (52nd and Madison) in New York City. The conference begins with registration at 7:00 a.m. Our 25-minute presentation, which will be webcast live, begins at 8:30 a.m. on Wednesday, September 19th, followed by a 25-minute Q&A breakout session. David Noel, VP of Finance & CFO, will be presenting for the company. The webcast of the presentation will be available live through Wall Street Webcasting. If you would like to listen, please access the following direct link to the webcast: http://www.wsw.com/webcast/clk4/lcbm/. The live broadcast as well as a replay will also be available through the investor relations section of Lifecore’s website at http://www.lifecore.com on the Presentation tab. About Lifecore Biomedical Lifecore Biomedical, in business over 40 years, develops, manufactures and markets biomaterials and medical devices for use in various surgical markets through two divisions, the Dental Division and the Hyaluronan Division. The Dental Division conducts its dental surgery business through direct sales and marketing in the United States, France, Germany, Italy and Sweden and through distributors in 49 other countries. The Hyaluronan Division conducts its business through OEM and contract manufacturing alliances in the ophthalmic, orthopedic and veterinary surgical fields. General Corporate Information is available on the internet at www.lifecore.com About CL King & Associates CL King & Associates, Inc. was founded in 1972 by Candace King Weir as an independent research boutique firmly committed to providing value-oriented research and analysis of investment opportunities exclusively for institutional investors. CL King is one of the first woman-owned securities firms in the United States and is a self-clearing registered broker/dealer. The firm makes markets in close to 300 securities, with eight industry analysts. CL King seeks to "Discover the Uncovered” by actively searching for underfollowed, unknown companies; more than 42% of the companies covered by the firm are followed by five or fewer sell-side analysts.